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Problem: We assess whether inflammatory and oxidative stress markers early in preg-
nancy are associated with decreasing cervical length in the second trimester.
Method of study: This is a secondary analysis of a nested case–control study of  preterm 
birth conducted at a tertiary care center from 2006 to 2008. Plasma inflammatory 
markers included the following: interleukin- 6 (IL- 6), interleukin- 10 (IL- 10), interleukin-
 1 beta (IL- 1β), tumor necrosis factor alpha (TNF- α), and C- reactive protein (CRP); and 
urine oxidative stress markers included the following: 8- hydroxydeoxyguanosine (8- 
OHdG) and 8- isoprostane, measured at two study visits (median 10 and 18 weeks of 
gestation). The primary outcome was cervical length<10th percentile measured 
between 16 and 24 weeks of gestation. Logistic regression models were used, adjust-
ing for body mass index, age, race, parity, tobacco use, education, and gestational age 
at cervical length measurement.
Results: Among 384 observed women, the 10th percentile cervical length was 3.0 cm. 
IL- 10 levels were significantly higher among women with a cervical length<10th per-
centile compared to women with a longer cervix (mean IL- 10: 95.5 vs 25.8 pg/mL, 
P<.01). Similarly, IL- 6 levels were significantly higher among women with a cervical 
length<10th percentile (mean IL- 6: 25.2 vs 4.3 pg/mL, P<.01). After controlling for 
potential confounders, an increase in IL- 10 was significantly associated with a cervical 
length<10th percentile at both 10 and 18 weeks (adjusted odd ratio [AOR]: 1.74; 95% 
CI: 1.18–2.58; P=.005). At 18 weeks, only IL- 6 was also significantly associated with a 
cervical length<10th percentile (AOR: 1.54; 95% CI: 1.11–2.13; P=.009). Other inflam-
matory biomarkers, including CRP, IL- 1β, TNF- α, and oxidative stress biomarkers, 
8- OHdG and 8- isoprostane, were not associated with cervical length.
Conclusion: There was a significant association between the cytokines IL- 6 and IL- 10 
early in pregnancy and decreased cervical length, suggesting an imbalance of immune 
regulation could impact cervical length.
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1.  | INTRODUCTION
Preterm birth is a significant public health problem, impacting over 10% 
of births worldwide.1 The underlying mechanisms leading to preterm 
birth remain poorly understood, and in many instances, preterm 
birth is preceded by asymptomatic shortening of the uterine cervix.2 
Women with a short cervix in the second trimester are at a substan-
tially increased risk of subsequent preterm birth.3 Inflammation and 
infection are among the most well- established precursors of preterm 
birth.4,5 Prior studies have focused on whether inflammatory markers 
are associated with preterm birth, but data remain limited with regard 
to these biomarkers in relation to mid- trimester cervical length.6–9
A number of biomarkers with known physiologic effects exist 
to measure both oxidative stress and inflammation.10,11 Pro- 
inflammatory cytokines are some of the most well- studied markers 
associated with preterm birth, most notably interleukin- 6 (IL- 6).7,12 
Another protein, interleukin- 10 (IL- 10), has been shown to be both a 
marker of inflammation as well as of anti- inflammation.13 C- reactive 
protein (CRP) is a strong marker of overall inflammation that has been 
shown to be associated with preterm birth. Oxidative stress, defined 
as an imbalance between antioxidant capacity and reactive oxygen 
species (ROS) generation, has received less attention, but has been 
implicated as playing a role in preterm birth.14 8- Isoprostane is a use-
ful biomarker of oxidative stress due to its stability, sensitivity to oxi-
dant injury, and specificity to arachidonic acid peroxidation by ROS.15 
8- hydroxydeoxyguanosine (8- OHdG), an oxidized nucleoside that is 
released in repair of damaged DNA, is also a commonly used marker of 
oxidative stress.16 In prior analyses, we have analyzed oxidative stress 
and inflammatory cytokine biomarkers longitudinally during pregnan-
cy in relation to preterm birth14,17; however, to date, there is limited 
data measuring these biomarkers at multiple time points in associa-
tion with cervical length among a large population of pregnant wom-
en6–9,17–19; and no studies have assessed oxidative stress markers in 
conjunction with cervical length.
In this study, we assessed whether five biomarkers of inflamma-
tion, including interleukin- 6 (IL- 6), interleukin- 10 (IL- 10), interleukin- 1 
beta (IL- 1β), tumor necrosis factor alpha (TNF- α), and CRP, and two 
biomarkers of oxidative stress, 8- hydroxydeoxyguanosine (8- OHdG) 
and 8- isoprostane, collected at two time points early in pregnancy 
(median 10 and 18 weeks gestation, respectively) were associated 
with decreasing cervical length between 16 and 24 weeks of gesta-
tion. We hypothesized that inflammatory pathways early in pregnancy 
implicated in preterm labor could also be a precursor to decreasing 
cervical length.
2  | MATERIALS AND METHODS
2.1 | Study population
This study is a secondary analysis of a case and control study of pre-
term birth conducted among women enrolled in the LIFECODES birth 
cohort at Brigham and Women’s Hospital (Boston, MA) from 2006 to 
2008.20 Briefly, in that original analysis, all singleton cases of preterm 
delivery (N=130) in the birth cohort were randomly matched 1:3 to 
singleton term controls (N=352).20 Similar to prior analyses from this 
dataset investigating secondary research questions, our goal was to 
characterize the association between biomarkers of inflammation and 
oxidative stress and cervical length in a population that would be gen-
eralizable to the overall cohort. We utilized inverse probability weight-
ings created from the probability of selection from the parent study 
population for cases (90.1%) and controls (33.9%).21 This adjustment 
negates the effect of oversampling preterm births and makes these 
results more generalizable to pregnant women in the base cohort pop-
ulation.22 The study was approved by the Institutional Review Board 
at Brigham and Women’s Hospital.
During the first trimester (median of 10 weeks gestation), enrolled 
women completed a demographic questionnaire, as well as supplied 
urine and blood samples for biomarker analysis. Participants provided 
plasma and urine samples at two time points generally before assess-
ment of second trimester cervical length (median 10 and 18 weeks 
of gestation, respectively). All women had samples at 10 weeks and 
333 (87%) of women had samples at 18 weeks either before or within 
1 week of cervical length assessment. Samples were also taken at 2 
study visits later in pregnancy (median 26 and 35 weeks), which were 
not used as a goal of the current analysis was to assess for a temporal 
relationship between biomarkers early in pregnancy and mid- trimester 
cervical length. Results of inflammation and oxidative stress biomark-
ers at all four time points in relation to preterm birth have been pre-
sented elsewhere.14,17
2.2 | Study variables
The following demographic variables were assessed at enrollment, 
including age, race/ethnicity, education, parity, body mass index (BMI) 
(calculated by dividing a subject’s weight by the square of her height, 
kg/m2), any tobacco use, alcohol use, and use of assisted reproductive 
technology.
The primary exposures were measures of inflammation, namely 
 IL- 6, IL- 10, CRP, IL- 1β, and TNF- α, and of oxidative stress, 8- OHdG and 
8- isoprostane. For the primary analysis, each biomarker was defined as 
an interquartile range (IQR) increase in the geometric average of lev-
els measured at 10 and 18 weeks gestation (or of one measure if two 
were not available); and then, biomarkers were assessed separately at 
10 and 18 weeks gestation. Distributions for both inflammation and 
oxidative stress biomarkers were natural log- transformed.
The primary outcome was cervical length, categorized into <10th 
percentile vs ≥10th percentile. The distribution of cervical length in 
the current study was consistent with prior large observational stud-
ies assessing the relationship between cervical length and the risk of 
spontaneous preterm birth.23,24 Cervical length in centimeters was 
assessed by ultrasound between 16 and 24 weeks at the time of fetal 
survey at a mean gestational age of 18.4 weeks (SD 1.43). Initial cer-
vical length assessment was performed transabdominally with more 
detailed evaluation performed transvaginally if clinically indicated 
or for either a cervical length <3.0 cm or an inability to adequately 
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visualize both the internal and external os. For cases of transvaginal 
measurement, once the probe was introduced and the cervical canal 
visualized, it was then slightly withdrawn to avoid compressing the cer-
vical stroma. Regardless of the probe type used, measurements were 
then made by tracing the distance between the visualized internal and 
external cervical os. This procedure was repeated with the shortest 
measurement being recorded. In this study, a single trained sonogra-
pher retrospectively reviewed measurements on existing ultrasound 
images to ensure uniformity of sonographic measurements.
2.3 | Oxidative stress and inflammatory 
biomarker analysis
Details about how oxidative stress and inflammatory biomarkers were 
measured and analyzed are described in detail in prior analyses.14,17 
Briefly, plasma samples were analyzed for inflammatory biomarkers at 
the University of Michigan Cancer Center Immunological Monitoring 
Core (Ann Arbor, MI, USA). Cytokines were analyzed using Milliplex 
MAP High Sensitivity Human Cytokine Magnetic Bead Panel (EMD 
Millipore Corp., St. Charles, MO, USA), and for individual measures 
below the limit of detection (LOD) (0.128 pg/mL for all cytokines), 
values reported numerically were kept as is. CRP was measured 
using a DuoSet enzyme- linked immunosorbent assay (R&D Systems, 
Minneapolis, MN, USA) and the lower LOD was 10 pg/mL and upper 
LOD was 100 pg/mL.
For oxidative stress markers, urine samples were stored at - 80C 
after collection until measurement. Both 8- OHdG and 8- isoprostane 
were measured by Cayman Chemical (Ann Arbor, MI, USA). For 
total 8- isoprostane, urine samples were hydrolyzed to deconjugate 
8- isoprostane esterified to phospholipids and were passed through 
affinity columns for purification. Eluted samples were then dried and 
resuspended in a buffer before measurement with enzyme immunoas-
say (EIA).14 The LOD was 3.9 pg/mL. For 8- OHdG, samples were dilut-
ed directly into buffer without purification, and concentrations were 
measured by EIA. The LOD was 10.3 pg/mL. Consistent with prior 
analyses, to account for urine dilution, specific gravity was measured 
in urine samples with a digital handheld refractometer (Atago Co, Ltd, 
Tokyo, Japan). Then to assess biomarker distributions and variability, 
concentrations of oxidative stress markers were corrected for specific 
gravity with the following formula: OSC=OS([1.015−1]/[SG−1]).
25 OSc 
represents the corrected biomarker concentration; OS is the uncor-
rected urinary concentration; 1.015 is the median specific gravity in all 
samples; and SG is the specific gravity of the sample.
2.4 | Statistical analysis
Distributions for both inflammation and oxidative stress biomarkers 
were ln- transformed (i.e., natural log- transformed) for data analy-
ses. The distribution of cervical lengths was tested for normality. As 
described above, we utilized inverse probability weightings created 
from the probability of selection from the parent study population 
in all unadjusted and adjusted regression models. Odds ratios (ORs) 
for being <10th percentile for cervical length were calculated for an 
association with a geometric average biomarker concentration calcu-
lated from the two study time points at 10 and 18 weeks gestation. 
Univariate models were adjusted for specific gravity for oxidative 
stress markers as they were drawn from urine samples. Multivariable 
models adjusted for a priori covariates that have been linked to short 
cervical length in previous studies,14,17,26 which included age, parity, 
race/ethnicity, education, tobacco use, BMI, and gestational age at 
assessment of cervical length. Additionally, separate multivariable 
logistic regression models at 10 and 18 weeks were constructed to 
investigate whether the association between biomarkers and cervical 
length differed in magnitude at a specific time point, adjusting for the 
same covariates above. We also conducted a sensitivity analysis at 
18 weeks excluding 51 women (13%) who had biomarkers measured 
>1 week after cervical length to determine whether the above results 
held for a temporal association. All analyses were performed using 
STATA (STATACORP, version 10.0, College Station, TX, USA).
3  | RESULTS
Among the 482 women included in the original case–control study 
of preterm birth, 402 (83%) women had a cervical length assessed 
on second trimester ultrasound. Of those, 11 women had a cervical 
length assessed either before 16 weeks or after 24 weeks and were 
hence excluded from the current analysis as this was outside the 
clinically proscribed window. An additional 7 women did not have bio-
marker measures from either study visit and were hence excluded. 
The  current analysis is limited to the remaining 384 women (80%), 
and there were no statistically significant differences (P<.05) between 
women in the current analysis compared to excluded women by 
maternal age, race, parity, BMI, tobacco use, or gestational age at 
delivery (data not shown).
Among the 384 pregnant women observed, the median age was 
32 years (IQR 28.7–35.8), over half (56%) were white, over two- thirds 
(67%) had completed a college education, and most women were 
multiparous (56%) (Table 1). Consistent with the original case–control 
study, 116 women (30%) delivered preterm (<37 weeks gestation). 
The median cervical length was 3.6 cm (IQR 3.2–4.1), and the 10th 
percentile was 3.0 cm. There were no statistically significant differenc-
es between women with a cervical length <10th percentile compared 
to women with a longer cervical length.
IL- 6 levels were markedly higher among women with a cervical 
length<10th percentile compared to women with a longer cervix 
(geometric mean IL- 6: 25.2 vs 4.3 pg/mL, P<.001) (Table 2). Similarly, 
IL- 10 levels were significantly higher among women with a cervical 
length<10th percentile (geometric mean IL- 10: 95.5 vs 25.8 pg/mL, 
P=.002). Other biomarkers of inflammation and oxidative stress did 
not significantly differ by cervical length.
We present unadjusted and adjusted analyses of the association 
between cervical length <10th percentile in association with an IQR 
increase in the geometric average of inflammatory and oxidative 
stress biomarkers in Table 3. In unadjusted analysis, IL- 10 was associ-
ated with an increased odds of cervical length <10th percentile (OR: 
     |  379Venkatesh et al.
1.61; 95% CI: 1.12–2.30; P=.009). In multivariable analyses of geo-
metric average biomarker concentrations, after adjusting for maternal 
race, age, parity, education, BMI, tobacco use, and gestational age at 
cervical length assessment, IL- 10 was significantly associated with an 
increased odds of cervical length <10th percentile (adjusted odd ratio, 
AOR: 1.74; 95% CI: 1.18–2.58; P=.005). No significant associations 
were observed for the inflammatory markers, IL- 6, IL- 1β, TNF- α, and 
CRP, and the oxidative stress markers, 8- OHdG and 8- isoprostane.
When associations between biomarkers and cervical length <10th 
percentile were examined separately at 10 and 18 weeks gestation, 
 IL- 6 was also significantly associated with an increased odds of cervical 
length <10th percentile at 18 weeks (AOR: 1.54; 95% CI:  1.11–2.13; 
P=.009), but not at 10 weeks (Table 4). Similar to the overall analysis, 
the association between IL- 10 and cervical length <10th percentile 
persisted at 10 weeks (AOR: 1.42; 95% CI: 1.01–1.99; P=.04) and 
18 weeks (AOR: 1.78; 95% CI: 1.20–2.65; P=.004).
We also conducted a sensitivity analysis at 18 weeks excluding 51 
women (13%) who had biomarkers measured >1 week after cervical 
length to determine a temporal association, and the adjusted ORs 
between IL- 6 (AOR: 1.67; 95% CI: 1.19–2.33; P=.003) and IL- 10 (AOR: 
1.99; 95% CI: 1.32–2.98; P=.001) and cervical length <10th percentile 
were even stronger. Given the possibility for over correction in adjust-
ed models between interrelated biomarkers and other variables in the 
final model, namely tobacco use and BMI, multivariable models were 
rerun adjusting for race, gestational age, and maternal age only, and 
these results were consistent with the overall findings.
TABLE  2 Distribution of inflammatory and oxidative stress 












IL- 6 (pg/mL) 6.69 (33.83) 25.18 4.33 <.001
IL- 10 (pg/mL) 33.62 (140.88) 95.47 25.79 .002
C- reactive 
protein (μg/mL)
10.06 (12.28) 11.21 9.92 .52
1L- IB (pg/mL) 1.13 (4.49) .68 1.19 .49
TNFa (pg/mL) 3.62 (5.30) 3.18 3.67 .57
Oxidative stress markers
8 OHDG 135.24 (127.86) 135.22 135.87 .97
8- isoprostane 272.59 (181.82) 263.27 273.82 .74
aStudent’s t test were used to compare geometric means between cervical 
length <10th percentile vs ≥10th percentile.
TABLE  3 Cervical length <10th percentile in association with an 
interquartile range increase in the geometric average of inflammatory 
and oxidative stress biomarkers
Biomarkers
Unadjusted analysis 
OR (95% CI); P- value
Adjusted analysis 
adjusted odd ratio 
(95% CI); P- valueb
Inflammatory markers
IL6 1.18 (0.78–1.79); .42 1.32 (0.91–1.91); .13
IL10 1.61 (1.12–2.30); .009 1.74 (1.18–2.58); .005
1L- IB 0.90 (0.60–1.35); .63 1.08 (0.65–1.79); .75
TNFa 0.61 (0.35–1.07); .08 0.58 (0.29–1.15); .12
C- reactive protein 0.98 (0.66–1.45); .94 1.09 (0.66–1.79); .72
Oxidative stress markers
8 OHDGa 1.04 (0.49–2.19); .91 1.09 (0.47–2.50); .82
8- isoprostanea 1.01 (0.64–1.58); .96 0.95 (0.57–1.57); .84
Bolded results reflect statistically significant findings (P<.05).
aAdjusted for urinary specific gravity.
bAdjusted for the following variables in multivariate analysis: maternal 
race, age, parity, education, body mass index, tobacco use, and gestational 
age at cervical length assessment. Models adjusted for inverse probability 
weightings.














<25 years 40 (10.4) 6 (14.6) 34 (9.9)
25–≤35 years 227 (59.1) 25 (61.0) 202 (58.9)
>35 years 117 (30.5) 10 (24.4) 107 (31.2)
Race/ethnicity
White 215 (56.0) 24 (58.5) 191 (55.7)
Black 67 (17.5) 5 (12.2) 62 (18.1)
Latina 55 (14.3) 8 (19.5) 47 (13.7)
Other or unknown 47 (12.2) 4 (9.8) 43 (12.5)
Educationc
High school or less 13 (3.4) 1 (2.6) 12 (3.6)
Junior college/some 
college
44 (11.7) 7 (18.0) 37 (11.0)
College graduate or 
greater
319 (84.8) 31 (79.5) 288 (85.5)
Parity
0 171 (44.5) 20 (49.8) 151 (44.0)
1+ 213 (55.5) 21 (51.2) 192 (56.0)
Tobacco use during 
pregnancyc
24 (6.3) 3 (7.5) 21 (6.2)
Alcohol use during 
pregnancyc
17 (4.5) 2 (5.0) 15 (4.4)
Use of assisted reproduc-
tive technology
35 (9.1) 5 (12.2) 30 (8.8)
Body mass index at enrollment
<25 kg/m2 198 (51.6) 26 (63.4) 172 (50.2)
25–30 kg/m2 104 (27.1) 7 (17.1) 97 (28.3)
>30 kg/m2 82 (21.3) 8 (19.5) 74 (21.6)
Gestational age at delivery
<37 weeks 116 (30.2) 18 (43.9) 98 (28.6)
37–≤39 weeks 112 (29.1) 11 (26.8) 101 (29.5)
>39 weeks 156 (40.6) 12 (29.2) 144 (42.0)
aThe above frequencies are of non- weighted results.
bThere were no statistically significant differences (P<.05) by cervical 
length for the above variables using chi- square statistic.
cMissing data for 2.1% of participants for education, 0.8% for tobacco use, 
and 1.6% for alcohol use.
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4  | COMMENT
The current study measured inflammatory and oxidative stress bio-
markers at two time points early in pregnancy before assessment of 
a shortened cervix among 384 pregnant women. We found a signifi-
cant association between the cytokines IL- 10 and IL- 6 and a cervi-
cal length <10th percentile, after adjusting for maternal race, age, 
parity, education, BMI, tobacco use, and gestational age at cervical 
length assessment. Notably, other inflammatory biomarkers, including 
CRP, IL- 1β, and TNF- α, and oxidative stress biomarkers, 8- OHdG and 
8- isoprostane, were not associated with cervical length. These results 
provide further evidence that an imbalance of immune regulation 
could impact cervical length, highlighting a critical gap in knowledge 
regarding cervical insufficiency.
We found that IL- 6 was associated with a cervical length <10th 
percentile at only 18 weeks, while IL- 10 was associated with a 
shortened cervix at both 10 and 18 weeks. This could be because 
IL- 6 increased later in pregnancy, while IL- 10 appeared unchanged 
throughout pregnancy.13,26,27 Prior studies conducted among smaller 
populations of pregnant women have noted an inconsistent associa-
tion between inflammatory markers and cervical length. Among 104 
women at high risk for preterm birth, inflammatory markers, includ-
ing elafin, surfactant protein- D, and IL- 6, were not associated with 
cervical length, both of which were measured twice between 20 and 
27 weeks.18 In another study among 94 women, the inflammatory 
markers IL- 1β, IL- 8, TNF- α, and matrix metalloproteinase- 8 measured 
in mid- trimester cervical fluid were also not associated with cervical 
length or shortening between 20 and 24 weeks.28 However, among 
41 women with a previous preterm birth, shorter mid- trimester cervi-
cal length was associated with pro- inflammatory cytokines (IL- 6, IL- 10, 
IL- 4, IL- 13, and IL- 1β).8 Another study conducted among 112 women 
with a previous preterm delivery found that only granulocyte–macro-
phage colony- stimulating factor and monocyte chemotactic protein- 1 
were increased among those women with a cervical length<25 mm; 
however, the majority of inflammatory markers (including IL- 8, IL- 8, 
and TNF- α) were not.9 Additionally, shortening of the cervix has been 
associated with the rate of rise of CRP among women with a short 
cervix from 20 to 33 weeks.19 Differences in results across studies 
may be due to the relatively small sample sizes (on average 50–100 
women), heterogeneity in study design, serum assay techniques, col-
lection of varying inflammatory markers, gestational age at collection, 
and patient populations studied.
These findings suggest that cervical shortening may not sim-
ply be anatomic in origin, but a shift in the normal balance of cervi-
cal inflammation may trigger biochemical and immunologic changes 
that precede mid- trimester cervical shortening.8,29 In a prior analysis 
of this dataset, IL- 6, IL- 10, as well as TNF- α were associated with an 
increased odds of preterm birth.4,17 In some studies, lower levels of IL- 
10 have been associated with an increased risk of preterm birth, which 
may be because IL- 10 is anti- inflammatory, while other studies have 
found no association.11,30,31 However, higher levels of IL- 10 associat-
ed with shortening of cervical length and preterm birth could be a nor-
mal physiologic response to an anti- inflammatory state.27 Both  IL- 6 
and IL- 10 have been shown to be highly correlated with each other in 
the current dataset,17 suggesting they may represent closely related 
physiologic processes. Future cellular and epidemiologic studies are 
needed to understand possible mechanisms that could explain these 
associations. Additionally, whether anti- inflammatory compounds that 
target anti- IL- 6 and IL- 10 activity upstream could be possible thera-
peutic interventions to prevent shortening of cervical length in preg-
nancy need to be studied.10
In the current study, we did not find an association between two 
measures of oxidative stress, 8- isoprostane and 8- OHdG, with short-
ening of cervical length. Of note, in a prior analysis, we found that 
8- isoprostane and 8- OHdG were associated with preterm birth, and 
these two oxidative stress markers were highest and associations 
with preterm birth were strongest later in pregnancy, compared to the 
current study which utilized these measures early in pregnancy prior 
to shortening of cervical length.14,32,33 However, not all studies have 
demonstrated an association between 8- isoprostane and 8- OHdG 
with preterm birth.34–36
This study must be interpreted within the context of its design. An 
important limitation is that a transvaginal ultrasound was performed 
only on those women in whom a cervical view could not be accurately 
obtained from transabdominal imaging at the time of the second tri-
mester fetal survey. Of note, the cervical length at the 75th and 25th 
percentile (4.1 and 3.3 cm) in the current study was very similar to 
prior large observational studies assessing the relationship between 
cervical length and the risk of spontaneous preterm birth (4 cm 
and 3 cm).23,24 Although prior research has demonstrated conflict-
ing results regarding the usefulness of transabdominal assessment 
of cervical length, recent studies comparing transvaginal to trans-
abdominal sonography of the cervix suggest that transabdominal 
TABLE  4 Cervical length <10th percentile in association with a 
natural log unit increase in inflammatory and oxidative stress 
biomarkers at visit 1 and visit 2
Biomarkers
Visit 1 Visit 2
Adjusted analysis 
adjusted odd ratio 
(AOR) (95% CI); 
P- valueb
Adjusted analysis 
AOR (95% CI); 
P- valueb
Inflammatory markers
IL- 6 1.06 (0.75–1.51); .70 1.54 (1.11–2.13); .009
IL1- 0 1.42 (1.01–1.99); .04 1.78 (1.20–2.65); .004
IL- 1B 0.83 (0.61–1.14); .26 0.84 (0.55–1.27); .41
TNFa 0.81 (0.46–1.43); .47 0.65 (0.36–1.18); .16
C- reactive protein 1.01 (0.70–1.46); .92 1.12 (0.72–1.73); .61
Oxidative stress markers
8 OHDGa 0.90 (0.57–1.44); .68 1.30 (0.51–3.31); .57
8- isoprostanea 1.04 (0.70–1.55); .81 0.89 (0.60–1.33); .57
Bolded results reflect statistically significant findings (P<.05).
aAdjusted for urinary specific gravity.
bAdjusted for the following variables in multivariate analysis: maternal 
race, age, parity, education, body mass index, tobacco use, and gestational 
age at cervical length assessment. Models adjusted for inverse probability 
weightings.
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cervical length may be shorter than or similar to mean transvaginal 
cervical length.37,38 These results will need to be replicated in women 
undergoing universal transvaginal screening for cervical length. In the 
current analysis, biomarker values below the LOD reported numeri-
cally were kept as is, and hence, calculated effect estimates may be 
attenuated compared to either excluding these values or substituting 
with the LOD. However, it is unlikely these values below the LOD 
had a significant impact on the effect estimates given that biomark-
ers with values below the LOD were infrequent (<5%). The current 
study utilized plasma and urinary biomarkers, and it is possible that 
markers closer to the maternal–fetal interface, such as amniotic or 
cervicovaginal fluid, would be more predictive of changes in cervi-
cal length.4 Additionally, cervical length was assessed at a single time 
point during fetal anatomic survey, and hence, we cannot comment 
on the contribution of these biomarkers to cervical length shortening 
over time relative to having a shorter cervix. This is a secondary anal-
ysis of nested case–control study of preterm birth, and these results 
may not be generalizable to all women. We utilized inverse probabili-
ty weighting to adjust for the effect of oversampling preterm births so 
that these results would be more generalizable to pregnant women in 
the base cohort population.
A strength of the current study is we utilized biomarker measure-
ments at two time points early in pregnancy before assessment of 
cervical length among a relatively large cohort of women, while many 
studies have relied on concurrent measurement of biomarkers and 
cervical length at one time point in smaller cohorts with <100 partic-
ipants. To our knowledge, following a MEDLINE search, the current 
study is the first study to investigate whether oxidative stress bio-
markers are associated with cervical length and is the largest sample 
size to assess inflammatory markers at two time points in relation to 
cervical length.
In conclusion, we observed that higher levels of IL- 6 and IL- 10 
early in pregnancy were associated with an increased risk of having 
a shorter cervix in the second trimester. A better understanding and 
characterization of the role of inflammatory and oxidative stress bio-
markers in the shortening of cervical length could lead to future tar-
geted prevention and treatment strategies earlier in the pathologic 
process before the onset of preterm labor.
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